Kyoto University eyes providing gene-edited iPS cells from 2023
The CiRA Foundation has already developed iPS cells using blood from donors who have types of immunity that make them less prone to transplant rejections.
Stay updated with breaking news from Cira Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The CiRA Foundation has already developed iPS cells using blood from donors who have types of immunity that make them less prone to transplant rejections.
Within these protective micro-environments, stem cells can achieve optimal growth in large-scale bioreactors, and can be differentiated into ready-to-transplant 3D microtissues.
Scientists in Japan from fiscal 2023 will apply technology to create induced pluripotent stem (iPS
Kyoto University The Hotta lab shows that protection from cellular RNA enhances the genome editing of iPS cells. The ability for scientists to edit human genomic DNA has been around for decades. Such research has revealed how a single mutation in just one of the billions of base pairs in the human genome can cause destructive diseases. In the past decade, advances in CRISPR-Cas9 technology have taken DNA editing a major step farther and promise to revolutionize regenerative medicine. One of the biggest challenges for therapeutic application is the efficiency of precise genome editing. A new...